Swiss Rockets, MGI US LLC and Full Genomics Inc. introduced at the moment that they entered right into a unique license settlement with MGI Tech and Full Genomics, USA, granting Swiss Rockets a perpetual, transferrable, sublicensable, freedom-to-operate, license for USA, Europe, Latam, Africa and Central Asia with choice to broaden rights into Asia-Pacific in 2026, protecting patents and different mental property vital for growth, manufacturing, and gross sales of the next-generation CoolMPS sequencing platform that can present sooner, cheaper and extra correct entire genome sequencing and different omics checks. The settlement contains funds linked to know-how switch and revenue-based royalties.
Swiss Rockets’ future growth will give attention to advancing CoolMPS merchandise with progressive learn barcoding. These improvements will help complete omics testing for superior genomic analysis and molecular well being monitoring.
CoolMPS chemistry supplies essentially the most superior MPS/NGS producing cost-effective Sanger sequencing high quality reads of 600-700bases. It additionally permits essentially the most correct typical 150-200b reads. Mixed with proprietary co-barcoding libraries the CoolMPS providing includes full haplotype-phased genome, transcriptome and microbiome sequencing for each illness prevention and optimum therapy choice, such in most cancers detection space.
It additionally permits essentially the most correct WGS-based early most cancers detection and MRD, when mixed with a particular sequencing library for cell-free dsDNA permitting to sequence each unique strands in a single DNA nanoball eliminating nearly all false somatic mutations as a consequence of DNA harm, or amplification and sequencing errors.
First CoolMPS sequencers, permitting cost-effective SE600+ reads for brand new functions resembling CompleteWGS, CompleteTranscriptome and CompleteMicrobiom are scheduled for early entry in Q1 2026
This thrilling deal between Swiss Rockets, MGI and Full Genomics will assist us to additional develop our breakthrough know-how CoolMPS and attain our unique imaginative and prescient of supporting longer wholesome dwelling by omics for all. “It is a dream coming true for me”, mentioned Dr Rade Drmanac, Chief Scientific Officer of MGI and Founding father of Full Genomics, “We now have all that’s wanted to make the most of full potential of our leading edge CoolMPS know-how.”
“This strategic license partnership with MGI and Full Genomics completely enhances Swiss Rockets’ superior precision therapeutic growth corporations”, mentioned Vladimir Cmiljanovic, Founder, CEO and Chairman of Swiss Rockets. “It permits us to supply inexpensive, correct and informative multi-omics checks in preventive well being and early diagnostics, in addition to efficient remedies in precision drugs and longevity.”
About Swiss Rockets AG:
Swiss Rockets AG, as each an incubator and accelerator, helps development of biotech and precision healthcare start-ups, notably within the subject of oncology. Its portfolio of radioligand therapies, small molecules and vaccines in pre-clinical and scientific stage, already drew consideration of the most effective international pharmaceutical corporations for future partnerships. Swiss Rockets AG was based by a group consisting of Dr. Vladimir Cmiljanovic, Chief Govt Officer; Dr. Natasa Cmiljanovic, Chief Working Officer; Manuel Ebner, Dr. Thomas Sander, and Dr. Thomas Staehelin.
About MGI
MGI Tech Co., Ltd. (or its subsidiaries, collectively known as MGI) is dedicated to constructing core instruments and applied sciences that drive innovation in life science. Our focus lies in analysis & growth, manufacturing, and gross sales of devices, reagents, and associated merchandise within the subject of life science and biotechnology. We offer real-time, multi-omics, and a full spectrum of digital tools and techniques for precision drugs, agriculture, healthcare, and numerous different industries.
Based in 2016, MGI has grown into a frontrunner in life science, serving prospects throughout six continents and establishing analysis, manufacturing, coaching, and after-sales service services globally. MGI stands out as one of many few corporations able to independently creating and mass-producing clinical-grade gene sequencers with various throughput capacities, starting from Gb to Tb ranges. With unparalleled experience, cutting-edge merchandise, and a dedication to international influence, MGI continues to form the trajectory of life sciences into the long run.
For extra data, please go to https://en.mgi-tech.com/, LinkedIn, X, and YouTube.
Full Genomics
Full Genomics is a pioneering life sciences firm that gives novel, finish to finish DNA sequencing options. It has been on the forefront of excessive throughput cost-effective sequencing know-how growth since its inception in 2005. Our merchandise have powered greater than 10,900 publications throughout a wide selection of functions. To be taught extra, go to www.completegenomics.com.
DISCLAIMER
Swiss Rockets AG has ready this press launch to the most effective of its data. The overall background details about Swiss Rockets AG’s actions is present as of the date of this press launch. This data is offered in abstract kind and doesn’t declare to be exhaustive. The knowledge contained on this press launch doesn’t represent a solicitation or provide to purchase, promote, or in any other case commerce or have interaction in any comparable transaction involving Swiss Rockets AG’s shares. The knowledge introduced herein contains sure forward-looking statements and estimates. Such data is topic to important scientific, financial, enterprise, and monetary uncertainties that can not be predicted upfront. Due to this fact, precise outcomes might materially differ from these projected. Neither Swiss Rockets AG nor its group corporations make any warranties, representations, or ensures relating to the information and knowledge made out there by this communication, together with however not restricted to their accuracy, timeliness, completeness, marketability, industrial usability, or suitability for any explicit function and particularly with regard to ahead wanting statements and doesn’t make any warranties or provides any ensures on the long run course of growth and success of any of its merchandise, methods or enterprise actions.
This disclaimer is ruled by Swiss regulation. Any disputes arising from or in reference to this press launch shall be topic to the unique jurisdiction of the competent courts of the Canton of Basel-Stadt, Switzerland.